Conditions: EPP XLP
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 184
Healthy volunteers: no

Brief summary:
The primary objective of this study is to investigate the efficacy of MT-7117 on time to onset and severity of first prodromal symptoms (burning, tingling, itching, or stinging) associated with sunlight exposure in adults and adolescents with EPP or XLP aged 12-75.

Detailed description:

Arms:
arm 1: Oral tablet of placebo once a day. arm 2: Oral tablet of MT-7117 Low Dose once a day. arm 3: Oral tablet of MT-7117 High Dose once a day.

Interventions: intervention 1: Placebo intervention 2: MT-7117 Low Dose intervention 3: MT-7117 High Dose
Intervention descriptions: intervention 1: Placebo intervention 2: MT-7117 Low Dose intervention 3: MT-7117 High Dose

Protocol document:
Prot_000.pdf: 







































































































































































































































































































































































































































































































SAP_001.pdf: